Fetal hypoxia causes PKCε gene repression in the heart resulting in heightened ischemic injury in male offspring in a sex-dependent manner. The present study tested the hypothesis that heightened methylation of the Egr-1 binding site at PKCε gene promoter contributes to sex dimorphism of hypoxia-induced programming of PKCε gene repression in the developing heart. Pregnant rats were divided into normoxic and hypoxic (10.5% O 2 from day 15 to 21 of gestation) groups. Hypoxia selectively decreased PKCε mRNA and protein abundance in the heart of male, but not female near-term (21d) fetuses. CpG methylation of the Egr-1 binding site was significantly increased in the male hearts by hypoxia, resulting in decreased Egr-1 binding affinity and reduced Egr-1 binding to the PKCε promoter. Nuclear Egr-1 levels were not affected by hypoxia. There was significant higher abundance of estrogen receptor α (ERα) and β (ERβ) isoforms in female than in male fetal hearts, which were not significantly altered by hypoxia. 
INTRODUCTION
Large epidemiological studies have shown that adverse environment in utero causes increased risk of developing endocrine and cardiovascular disorders such as diabetes, hypertension and ischemic heart disease in adult life (4, 5, 9, 11, 21, 32) . Hypoxia during gestation is one of the most common insults to the fetal development and is thought to be associated with fetal intrauterine growth restriction and increased risk of cardiovascular dysfunction in offspring (3, 12, 22, 25, 35) . Recent studies in rats have found that maternal hypoxia results in developmental programming of heightened heart vulnerability to ischemia and reperfusion injury in male offspring in a sex-dependent manner (3, 22) . Among other mechanisms, it has been demonstrated that repression of protein kinase C epsilon (PKCε) gene in the developing heart is a congruent mechanism for programming of increased heart susceptibility to ischemia and reperfusion injury in offspring (2, 19, 24, 35) .
DNA methylation is a chief mechanism for epigenetic modification of gene expression patterns that are essential for development and differentiation and allow an organism to respond to the environment. Our recent studies demonstrated that fetal hypoxia increased CpG methylation of the Sp1 binding sites at rat PKCε gene promoter, which contributed to PKCε gene repression in the developing heart (29). Subsequently, our studies also demonstrated a key role of the Egr-1 binding site in the regulation of PKCε promoter activity in fetal rat hearts (18). Yet, it R-00461-2012. R1 7 min, and treated with sodium bisulfite at 55°C for 16 h, as previously described (18). DNA was purified with a Wizard DNA clean up system (Promega) and resuspended in 120 µl of H 2 O.
Bisulfite-treated DNA was used as a template for real-time fluorogenic methylation-specific PCR (MSP) using primers created to amplify promoter sequences containing Egr-1 binding site based on the previous sequencing of rat PKCε promoter (18). Real-time MSP was performed using the iQ SYBR Green Supermix with iCycler real-time PCR system (Bio-Rad).
Electrophoretic mobility shift assay (EMSA). Nuclear extracts were collected from hearts using NXTRACT CelLytic Nuclear Extraction Kit (Sigma). The oligonucleotide probes with CpG and m CpG of the Egr-1 binding site at rat PKCε promoter region were labeled and subjected to gel shift assays using the Biotin 3′ end labeling kit and LightShift Chemiluminescent EMSA Kit (Pierce Biotechnology, Rockford, IL), as previously described (21). Briefly, single stranded oligos were incubated with Terminal Deoxynucleotidyl Transferase (TdT) and Biotin-11-dUTP in binding mixture for 30 min at 37ºC. The TdT adds a biotin labeled dUTP to the 3'-end of the oligonucleotides. The oligos were extracted using chloroform and isoamyl alcohol to remove the enzyme and unincorporated biotin-11-dUTP. Dot blots were performed to ensure the oligos were labeled equally. Combining sense and antisense oligos and exposing to 95ºC for 5 min was done to anneal complementary oligos. The labeled oligonucleotides were then incubated with or without nuclear extracts in the binding buffer (from LightShift kit). Binding reactions were performed in 20 μl containing 50 fmol oligonucleotide probes, 1× binding buffer, 1 μg of poly (dI-dC), and 5 μg of nuclear extracts. For competitions studies, increasing concentrations of non-labeled oligonucleotides were added to binding reactions. The samples were then run on a native 5% polyacrylamide gel. The contents of the gel were then transferred to a nylon membrane (Pierce) and crosslinked to the membrane using a UV crosslinker (125 mJoules/cm 2 ). Membranes were blocked and then visualized using the reagents provided in the LightShift kit.
Chromatin immunoprecipitation (ChIP).
Chromatin extracts were prepared from hearts.
ChIP assays were performed using the ChIP-IT kit (Active Motif), as previously described (18).
Briefly, heart tissues were incubated with 1% formaldehyde for 10 min to crosslink and maintain DNA/protein interactions. After the reactions were stopped with glycine, tissues were washed, and chromatin was isolated and sheared into medium fragments (100 -1000 base pairs) using a sonicator. ChIP reactions were performed using an Egr-1 antibody or ERα and ERβ antibodies to precipitate the transcription factor/DNA complex. Crosslinking was then reversed using a salt solution and the proteins were digested with proteinase K. Primers flanking the Egr-1 binding site were used for PCR: 5′-GATCCGAGGAGCACAGAC-3′ (forward) and 5′-GTGAGCCGAGCAGAAAAC-3′ (reverse). PCR amplification products were visualized on 2% agarose gel stained with ethidium bromide. To quantify PCR amplification, 45 cycles of realtime PCR were carried out with 3 min initial denaturation followed by 95°C for 30 s, 59°C for 30 s, and 72°C for 30 s, using the iQ SYBR Green Supermix with iCycler real-time PCR system (Bio-Rad).
Statistical analysis. Data are expressed as mean ± SEM. Statistical significance (P < 0.05) was determined by analysis of variance (ANOVA) followed by Neuman-Keuls post hoc testing or Student's t test, where appropriate.
RESULTS

Hypoxia decreases
PKCε expression in fetal hearts in a gender-dependent manner. Fig.   1 shows that maternal hypoxia resulted in significant decreases in both protein and mRNA abundance of PKCε in male, but not female fetal rat hearts.
Hypoxia increases CpG methylation of the Egr-1 binding site. Maternal hypoxic treatment caused a significant increase in CpG methylation of the Egr-1 binding site in male fetal hearts ( Fig. 2A) . In female hearts, the hypoxia-mediated increase of CpG methylation of the Egr-1 binding site was moderate but also significant, which was significantly reduced as compared with that seen in males ( Fig. 2A) . (Fig. 3) . In contrast, the binding of Egr-1 to the PKCε promoter in female fetal hearts was not significantly altered (Fig. 3) . Moreover, Egr-1 abundance in nuclear extracts of either male or female fetal hearts has no significant difference between hypoxia-treated and control animals (data not shown). Egr-1 binding to the PKCε promoter, and decreased PKCε mRNA and protein abundance in the hearts of 3 months old male offspring that had been exposed to hypoxia before birth. In contrast, the hearts of female offspring were not significantly affected (Fig. 7) .
Methylation of the
Inhibition
DISCUSSION
Our previous studies demonstrated that prenatal hypoxia caused an increase in heart susceptibility to ischemia and reperfusion injury in a sex-dependent manner, which was due to In the present study, we demonstrated further that, in addition to the Sp1 binding site, ERα and ERβ also bound to the Egr-1 binding site at PKCε promoter in fetal hearts, which was significantly greater in female hearts than male hearts. Whereas the interaction of ER and Sp1 binding sites has been well documented in the previous studies (28), the binding of ER to Egr-1 binding sites has not been previously reported. Thus, the present study provides a novel finding and suggests a new mechanism of ER in protecting promoter methylation in female hearts, which may contribute to the sex dimorphism of hypoxia-induced programming of PKCε gene expression patterns in the developing heart. The finding that the sex dichotomy of Egr-1 site methylation and transcription factor binding observed in fetal hearts were sustained in the hearts of 3 months old offspring suggests the long-term effect of ER-mediated protection of PKCε gene expression in the developing heart. Future studies are needed to determine whether ER binds to the Egr-1 binding site directly or through a protein-protein interaction with the Egr-1 transcription factor.
Egr-1 is a nuclear protein with sequence-specific DNA binding activity and it is suggested as an intracellular "third messenger" by regulating expression of multiple downstream target genes (16) . It has been reported that Egr-1 is over expressed in the heart after ischemia and reperfusion challenge (1, 8) . Down-regulation of Egr-1 expression has been shown to have a potential protective effect on heart ischemia and reperfusion injury (6, 13, 38) . Accordingly, methylation of the Egr-1 binding site at PKCε gene promoter in the heart could be a selfprotection mechanism against enhanced susceptibility to ischemia and reperfusion-mediated injury induced by hypoxia. Therefore, the present study proceeded to determine the potential epigenetic regulating roles of Egr-1 binding site in prenatal hypoxia induced sex-dependent down-regulation of PKCε gene in fetal and adult offspring hearts. In the present study, we found that prenatal chronic hypoxia significantly increased the methylation level of Egr-1 binding site at PKCε promoter in male fetal and adult offspring hearts, whereas little or no increasing of Egr-1 binding site methylation at PKCε promoter was found in female fetal or adult hearts.
Although the previous study showed that an extended 5'-deletions of the PKCε promoter from -1163 to -444, which contains the Egr-1 binding site at -1008, as well as multiple other binding sites, had no significant effect on the promoter activity (37), the more confined deletion from -1163 to -826 in another study revealed a significant decrease in the PKCε promoter In the present study, the extent of decreased Egr-1 binding in intact chromatin was comparable to that of increased methylation at the Egr-1 binding site in male fetal and adult offspring hearts. However, no difference was observed in both female fetal and adult offspring hearts. The sex-different changes of PKCε mRNA and protein abundance were consistent with alterations in the methylation pattern of Egr-1 binding site and Egr-1 binding to PKCε promoter in both fetal and adult offspring hearts, suggesting that changes in CpG methylation and Egr-1 binding to the Egr-1 binding site play a key role in the sex-dependent epigenetic modification of PKCε expression in the heart. It has been reported that gender differences exist in susceptibility to and mortality from a variety of cardiovascular diseases (20). Recent studies in animal models and cardiomyocytes further showed that female hearts had greater resistance to ischemia and reperfusion-mediated injury (30, 33). Besides the possible roles of sex steroid hormones, sex specific molecular cell death pathways, sex specific myocardial inflammatory response and differences between genetically male (XX) and female (XY) cells (14, 30, 33) , the underlying mechanisms of the sex-different susceptibility to cardiovascular diseases is far less clear. Indirect evidence including the reduced risk of cardiovascular diseases in premenopausal women and in post-menopausal women with estrogen replacement therapy pointed to the protective effect of estrogen in the heart (27). In a recent publication, Lancaster and colleague provide a strong rationale for the efficacy of acute PKCε activation to improve ischemic tolerance with postmenopausal estrogen deficiency (17), which indicated the possible cardioprotective role of PKCε through an estrogen/ER pathway.
Although it is plausible to speculate a primary role of sex hormones developed postnatally for the sex dichotomy seen in fetal programming of adult disease, our previous studies demonstrated that fetal hypoxia and cocaine exposure caused sex-dependent changes in PKCε gene expression patterns in hearts of fetuses and neonates before the sexual maturity (29, 37). The finding of greater expression of ERα and ERβ in the hearts of female fetuses is intriguing, and may suggest a mechanism for the sex difference in the early developmental stage of programming. Although the mechanisms of differential ER expression in male and female fetuses are not clear at present, it is possible that ER expression may be based upon X chromosomal activity (31). Additionally, maternal estrogen may be handled differently by the placenta of female and male fetuses. Although ER acts as ligand-gated receptor to alter gene expression by binding to consensus estrogen response element (ERE) sites on the promoter, ER may also function in a ligand-independent manner to alter gene transcription. ER can be phosphorylated allowing it to bind to ERE, or bind to DNA indirectly via another transcriptional factor, which is referred to as "transcriptional cross-talk" (26). It has been reported that ER can bind to DNA via transcriptional factors such as Ap1 and Sp1 (7, 15) . Our previous study also demonstrated that both ERα and ERβ bound to the Sp1 binding site at the PKCε promoter in intact chromatin in the fetal heart (29), suggesting a possible protective role of ER by increasing Sp1 binding and PKCε transcription in the female hearts in response to hypoxic stress. The present finding that ER bound to the Egr-1 binding site provides a new target of transcription factor binding site in which ER may interact and regulate promoter activity and gene expression.
Perspectives and significance
The sex difference is often observed in developmental programming of adult disease from large epidemiological as well as animal studies. Although female sex hormone estrogen produced postnatally is often thought to be a primary mechanism, recent findings of sex-dependent programming in early developmental stages before the sexual maturity suggest much earlier effects of sex hormones. The present study provides a novel finding and suggests a new mechanism of ER in protecting promoter methylation by binding to the Egr-1 binding site in fetal hearts, contributing to the sex dimorphism of fetal hypoxia-induced programming of PKCε gene expression patterns in the developing heart. Although the caution should be observed in extrapolating the findings of animal studies directly to humans, several lines of evidence suggest a possible clinical significance of these studies. Thus, hypoxia is one of the most important and clinically relevant stresses to the fetus. The previous study has demonstrated that fetal hypoxia has distinct effects on programming of cardiovascular function, which is independent from the maternal nutrient status (34). Although gross adverse effect to the fetus may not be observed for pregnant women travelling to altitude, the notion that hypoxia may cause subtle epigenetic modifications of gene expression patterns in the fetus leading to abnormal function later in life cannot be excluded. Given that repression of PKCε gene in the developing heart is a congruent mechanism for fetal stress-mediated programming of increased heart susceptibility to ischemia and reperfusion injury in offspring (2, 19, 24, 36) , the present study provides a new mechanism in our understanding of the sex dichotomy in epigenetic modifications of gene expression patterns in developmental programming of cardiac function in response to adverse intrauterine environment. 
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